Author
Tamás Radovits
Semmelweis UniversityORCID 0009-0009-4090-776XUnclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2024-2026 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 44 mutual co-author links4 papers
Recent·Most cited
- ImmunologyBritish Journal of PharmacologyPeer-reviewed2 citations
- ImmunologybioRxivPreprint
Prevention of mRNA vaccine-induced anaphylaxis by peripheral cyclooxygenase inhibitors in an anti-PEG hyperimmune pig model: clinical relevance for nanomedicine-induced infusion reactions
Bálint András Barta, Tamás Radovits, Attila Balázs Dobos…·János Szebeni
This study identifies cyclooxygenase inhibitors as effective in preventing mRNA vaccine-induced anaphylaxis in a hyperimmune pig model, suggesting potential clinical applications for nanomedicine infusion reactions.
DOI 10.64898/2026.05.27.727997 - ImmunologybioRxivPreprint
Hemoperfusion of pigs with a carbon-cellulose cartridge: a pilot study revealing a new animal model of extended anaphylactic shock
Bálint András Barta, Tamás Radovits, Sylvia Spiesshofer…·János Szebeni
This study uses a porcine model to investigate anaphylactoid reactions caused by a carbon-cellulose cartridge, revealing mechanisms of cardiovascular collapse and shock.
DOI 10.64898/2026.03.05.709860 - ImmunologyInternational Journal of Molecular SciencesPeer-reviewed
mRNA-LNP COVID-19 vaccine lipids induce low level complement activation and production of proinflammatory cytokines: Mechanisms, effects of complement inhibitors, and relevance to adverse reactions
Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma…·János Szebeni
This study investigates how mRNA-LNP vaccines trigger complement activation and cytokine production, linking these processes to inflammatory adverse events and suggesting potential therapeutic strategies.
54 citationstop 1%